Peptide Therapeutics Market, By Type (Branded Peptide, Generic Peptide), By Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, Others), By Route of Administration (Oral Administration, Parenteral Admin

Peptide Therapeutics Market, By Type (Branded Peptide, Generic Peptide), By Application (Cancer, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Infectious Disease, Others), By Route of Administration (Oral Administration, Parenteral Administration, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Peptide therapeutics continue to expands its application by broaden molecular diversity and by engineering enhanced pharmaceutical properties. Research continues to expand the potential range of peptide-based pharmaceuticals to focus on treatment targets. However, large number of peptide targets shown in its early-stage of clinical trials or in preclinical models of disease, such as a melanocortin 4 receptor (MC4R) agonist, may reduce the body weight of patients with genetic obesity syndromes.
Furthermore, increasing development are in progress to extend the half-life period of peptide drugs; to improve the oral bioavailability of peptide therapeutics and to enhance the Central Nervous System (CNS) availability of peptide drugs through nanoparticle delivery in the indications such as Alzheimer’s disease and stroke.
Market Dynamics
Market players are engaged in developing novel and innovative peptide therapeutics drugs in order to offer tailored solution to target patient by increasing biocompatibility and potent therapeutic effects. Increasing prevalence of cancer and diabetes mellitus is projected to drive growth of the peptide therapeutics market over the forecast period. Also, clinical development in the field of peptide reflects it as an effective tool for molecular pharmacology.
Key features of the study:
This report provides in-depth analysis of peptide therapeutics in medical sector and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global peptide therapeutics market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Takeda Pharmaceuticals Co. Ltd., Novo Nordisk A/S, Eli Lilly and Company, Sanofi S.A., Encycle Therapeutics, Inc., CirclePharma, Inc., Pfizer Inc., Novartis AG, PeptiDream Inc., Amgen Inc., among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion and marketing tactics
The global peptide therapeutics market report caters to various stakeholders in this industry including investors, suppliers, peptide therapeutics based product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the peptide therapeutics market.
Detailed Segmentation:
Global Peptide Therapeutics Market, By Type:
Branded Peptide
Generic Peptide
Global Peptide Therapeutics Market, By Application:
Cancer
Cardiovascular Disease
Metabolic Disease
Respiratory Disease
Infectious Disease
Others
Global Peptide Therapeutics Market, By Route of Administration:
Oral Administration
Parenteral Administration
Others
Global Peptide Therapeutics Market, By Geography:
North America
By Country:
U.S.
Canada
By Type:
Branded Peptide
Generic Peptide
By Application
Cancer
Cardiovascular Disease
Metabolic Disease
Respiratory Disease
Infectious Disease
Others
By Route of Administration:
Oral Administration
Parenteral Administration
Others
Europe
By Country:
Germany
France
Italy
UK
Spain
Russia
Rest of Europe
By Type:
Branded Peptide
Generic Peptide
By Application
Cancer
Cardiovascular Disease
Metabolic Disease
Respiratory Disease
Infectious Disease
Others
By Route of Administration:
Oral Administration
Parenteral Administration
Others
Asia Pacific
By Country:
China
India
Japan
South Korea
Australia
Rest of Asia Pacific
By Type:
Branded Peptide
Generic Peptide
By Application
Cancer
Cardiovascular Disease
Metabolic Disease
Respiratory Disease
Infectious Disease
Others
By Route of Administration:
Oral Administration
Parenteral Administration
Others
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Type:
Branded Peptide
Generic Peptide
By Application
Cancer
Cardiovascular Disease
Metabolic Disease
Respiratory Disease
Infectious Disease
Others
By Route of Administration:
Oral Administration
Parenteral Administration
Others
Latin America
By Country:
Brazil
Argentina
Mexico
Rest of Latin America
By Type:
Branded Peptide
Generic Peptide
By Application
Cancer
Cardiovascular Disease
Metabolic Disease
Respiratory Disease
Infectious Disease
Others
By Route of Administration:
Oral Administration
Parenteral Administration
Others
Africa
By Country:
South Africa
Central Africa
North Africa
By Type:
Branded Peptide
Generic Peptide
By Application
Cancer
Cardiovascular Disease
Metabolic Disease
Respiratory Disease
Infectious Disease
Others
By Route of Administration:
Oral Administration
Parenteral Administration
Others
Company Profiles
Teva Pharmaceutical Industries Ltd.*
Company Overview
Product Portfolio
Financial Performance
Recent Developments
Strategies
Takeda Pharmaceuticals Co. Ltd.
Novo Nordisk A/S
Eli Lilly and Company
Sanofi S.A.
Encycle Therapeutics, Inc.
CirclePharma, Inc.
Pfizer Inc.
Novartis AG
PeptiDream Inc.
Amgen Inc.
“*” marked represents similar segmentation in other categories in the respective section.